Author

Deepak S. Chauhan

Dalhousie UniversityORCID 0000-0001-8602-6006Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Channakeshava Sokke UmeshappaiD· 2 shared Harish Babu KollaiD· 2 shared Roopa Hebbandi NanjundappaiD· 2 shared Aahana Palyada· 1 shared Anuj KumariD· 1 shared Briley Hillyard· 1 shared David J. KelviniD· 1 shared Jean Marshal· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Channakeshava Sokke UmeshappaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintSep 18, 2025

Targeted αGalCer/CD1d Therapy Engages Invariant Natural Killer T Cells to Facilitate Cardiac Healing in Chronic Doxorubicin-Induced Cardiomyopathy

Sarojini Singh, Roopa Hebbandi Nanjundappa, Harish Babu Kolla…·Channakeshava Sokke Umeshappa

This study investigates the role of iNKT cells in cardiac healing using GalCer/CD1d therapy in a Doxorubicin-induced cardiomyopathy model, finding increased IFN-γ and IL-10 without worsening cardiac damage.

DOI 10.1101/2025.09.18.676932

mouseexperimental assay

𝕏 PostBluesky

ImmunologybioRxivPreprintApr 17, 2024

Advancing Tolerogenic Immunotherapy: A Multi-Epitope Vaccine Design Targeting the CYP2D6 Autoantigen in Autoimmune Hepatitis Through Immuno-Informatics

Harish Babu Kolla, Anuj Kumar, Roopa Hebbandi Nanjundappa…·Channakeshava Sokke Umeshappa

This paper designs a multi-epitope tolerogenic vaccine targeting CYP2D6 for autoimmune hepatitis using immuno-informatics, showing it induces IL-10 and programs dendritic cells toward a tolerogenic state.

DOI 10.1101/2024.04.17.589809

mouseproteomics

𝕏 PostBluesky